Preclinical News and Research

RSS
Researchers demonstrate potential of new PET tracer for imaging prostate cancer

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

New clinical trial examines potential role of drug combination therapy to eliminate LAM cells

New clinical trial examines potential role of drug combination therapy to eliminate LAM cells

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Biologic substance APOSEC shows promise for healing dermal wounds

Biologic substance APOSEC shows promise for healing dermal wounds

Researchers ferreting out patients most likely to become resistant to cancer treatment

Researchers ferreting out patients most likely to become resistant to cancer treatment

Researchers develop ceramic skull implant to deliver ultrasound treatments through thick skulls

Researchers develop ceramic skull implant to deliver ultrasound treatments through thick skulls

Takeda and Cardurion announce creation of new cardiovascular development partnership

Takeda and Cardurion announce creation of new cardiovascular development partnership

MR Solutions’ dry magnet system provides high resolution imaging within compact footprint

MR Solutions’ dry magnet system provides high resolution imaging within compact footprint

Expert highlights CRISPR’s applications, limitations, and ethical concerns

Expert highlights CRISPR’s applications, limitations, and ethical concerns

Novel imaging tracer can help assess patient’s rupture risk for abdominal aortic aneurysm

Novel imaging tracer can help assess patient’s rupture risk for abdominal aortic aneurysm

New drug may limit disease progression, provide better symptom relief to Parkinson's patients

New drug may limit disease progression, provide better symptom relief to Parkinson's patients

Experiments in big animals show efficacy of new non-toxic MRI contrast agent

Experiments in big animals show efficacy of new non-toxic MRI contrast agent

Juvenescence AI to develop first compounds generated by Insilico's deep-learned drug discovery engines

Juvenescence AI to develop first compounds generated by Insilico's deep-learned drug discovery engines

Stem cell-based method selectively targets cancerous tissue while preventing toxic side effects

Stem cell-based method selectively targets cancerous tissue while preventing toxic side effects

Researchers discover potential chemical 'silver bullet' to reduce risk of colon cancer

Researchers discover potential chemical 'silver bullet' to reduce risk of colon cancer

Study assesses upper, lower extremity muscle function in Osteogenesis Imperfecta Type IV

Study assesses upper, lower extremity muscle function in Osteogenesis Imperfecta Type IV

Preclinical study demonstrates efficacy of gene therapy in treatment of Duchenne muscular dystrophy

Preclinical study demonstrates efficacy of gene therapy in treatment of Duchenne muscular dystrophy

Researchers present novel gene-editing technique to prevent retinal angiogenesis

Researchers present novel gene-editing technique to prevent retinal angiogenesis

CUMC researchers capture first snapshot of key brain receptor in action

CUMC researchers capture first snapshot of key brain receptor in action

University of Birmingham joins €19 million project to develop better treatments for heart disease

University of Birmingham joins €19 million project to develop better treatments for heart disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.